Are Microparticles the Missing Link between Thrombosis and Autoimmune Diseases? Involvement in Selected Rheumatologic Diseases

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 6, 2014, Pages 675-681

  Cunningham, Melissa ^a   Marks, Natalia ^b   Barnado, April ^a   Wirth, Jena R ^a   Gilkeson, Gary ^a   Markiewicz, Margaret ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

lupus erythematosus; microparticles; rheumatoid arthritis; systemic; systemic sclerosis; thrombosis

Indexed keywords

AGING; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; HUMAN; HYPERCOAGULABILITY; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MEMBRANE MICROPARTICLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOSIS; AGE; ANIMAL; IMMUNOLOGY; METABOLISM; RISK FACTOR;

AGE FACTORS; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CELL-DERIVED MICROPARTICLES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS; THROMBOSIS;

EID: 84928383782     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1387924     Document Type: Review

References (97)

1. Zöller B., Li X., Sundquist J., Sundquist K. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis: 2012; 2 3 171 183
2. Rosendaal F. R. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost: 1997; 78 1 1 6
3. Favaloro E. J., Franchini M., Lippi G. Aging hemostasis: changes to laboratory markers of hemostasis as we agea narrative review. Semin Thromb Hemost: 2014; 40 6 621 633
4. Tracy R. P., Bovill E. G. Thrombosis and cardiovascular risk in the elderly. Arch Pathol Lab Med: 1992; 16 1307 1312
5. Celermajer D. S., Sorensen K. E., Bull C., Robinson J., Deanfield J. E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol: 1994; 24 6 1468 1474
6. Ershler W. B. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc: 1993; 41 2 176 181
7. Bonfigli A. R., Sirolla C., Cenerelli S., et al. Plasminogen activator inhibitor-1 plasma level increases with age in subjects with the 4G allele at position -675 in the promoter region. Thromb Haemost: 2004; 92 5 1164 1165
8. Markiewicz M., Richard E., Marks N., Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res: 2013; 2013 734509
9. Brandes R. P., Fleming I., Busse R. Endothelial aging. Cardiovasc Res: 2005; 66 2 286 294
10. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res: 2001; 88 8 756 762
11. Garg U. C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest: 1989; 83 5 1774 1777
12. Linton P., Thoman M. L. T cell senescence. Front Biosci: 2001; 6 D248 D261
13. Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev: 2006; 5 2 136 139
14. Antonaci S., Jirillo E., Bonomo L. Immunoregulation in aging. Diagn Clin Immunol: 1987; 5 2 55 61
15. Kendall M. D., Johnson H. R., Singh J. The weight of the human thymus gland at necropsy. J Anat: 1980; 131 Pt 3 483 497
16. Subbarao B., Morris J., Kryscio R. J. Phenotypic and functional properties of B lymphocytes from aged mice. Mech Ageing Dev: 1990; 51 3 223 241
17. Utsuyama M., Hirokawa K., Kurashima C., et al. Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech Ageing Dev: 1992; 63 1 57 68
18. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M. F., Quaglino D. Immunological changes in the elderly. Aging (Milano): 1999; 11 5 281 286
19. Goronzy J. J., Fujii H., Weyand C. M. Telomeres, immune aging and autoimmunity. Exp Gerontol: 2006; 41 3 246 251
20. Costenbader K. H., Prescott J., Zee R. Y., De Vivo I. Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease? Autoimmun Rev: 2011; 10 9 569 573
21. Distler J. H., Huber L. C., Gay S., Distler O., Pisetsky D. S. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity: 2006; 39 8 683 690
22. Roos M. A., Gennero L., Denysenko T., et al. Microparticles in physiological and in pathological conditions. Cell Biochem Funct: 2010; 28 7 539 548
23. Puddu P., Puddu G. M., Cravero E., Muscari S., Muscari A. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol: 2010; 26 4 140 145
24. Burger D., Montezano A. C., Nishigaki N., He Y., Carter A., Touyz R. M. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol: 2011; 31 8 1898 1907
25. Leroyer A. S., Anfosso F., Lacroix R., et al. Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost: 2010; 104 3 456 463
26. Owens A. P. III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res: 2011; 108 10 1284 1297
27. Burnier L., Fontana P., Kwak B. R., Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost: 2009; 101 3 439 451
28. Horstman L. L., Ahn Y. S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol: 1999; 30 2 111 142
29. Flaumenhaft R., Dilks J. R., Richardson J., et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood: 2009; 113 5 1112 1121
30. Rozmyslowicz T., Majka M., Kijowski J., et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS: 2003; 17 1 33 42
31. Chirinos J. A., Heresi G. A., Velasquez H., et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol: 2005; 45 9 1467 1471
32. Preston R. A., Jy W., Jimenez J. J., et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension: 2003; 41 2 211 217
33. Tans G., Rosing J., Thomassen M. C., Heeb M. J., Zwaal R. F., Griffin J. H. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood: 1991; 77 12 2641 2648
34. Knijff-Dutmer E. A., Koerts J., Nieuwland R., Kalsbeek-Batenburg E. M., van de Laar M. A. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum: 2002; 46 6 1498 1503
35. Pereira J., Alfaro G., Goycoolea M., et al. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost: 2006; 95 1 94 99
36. Nielsen C. T., Østergaard O., Stener L., et al. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum: 2012; 64 4 1227 1236
37. Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circ Res: 2012; 110 2 356 369
38. Lacy P. Mechanisms of degranulation in neutrophils. Allergy Asthma Clin Immunol: 2006; 2 3 98 108
39. Gasser O., Hess C., Miot S., Deon C., Sanchez J. C., Schifferli J. A. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res: 2003; 285 2 243 257
40. Hess C., Sadallah S., Hefti A., Landmann R., Schifferli J. A. Ectosomes released by human neutrophils are specialized functional units. J Immunol: 1999; 163 8 4564 4573
41. Gasser O., Schifferli J. A. Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement. Exp Cell Res: 2005; 307 2 381 387
42. Mesri M., Altieri D. C. Endothelial cell activation by leukocyte microparticles. J Immunol: 1998; 161 8 4382 4387
43. Mesri M., Altieri D. C. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem: 1999; 274 33 23111 23118
44. Gasser O., Schifferli J. A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood: 2004; 104 8 2543 2548
45. Brodsky S. V., Zhang F., Nasjletti A., Goligorsky M. S. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol: 2004; 286 5 H1910 H1915
46. Dalli J., Norling L. V., Renshaw D., Cooper D., Leung K. Y., Perretti M. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood: 2008; 112 6 2512 2519
47. Pluskota E., Woody N. M., Szpak D., et al. Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood: 2008; 112 6 2327 2335
48. Satta N., Freyssinet J. M., Toti F. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br J Haematol: 1997; 96 3 534 542
49. Aharon A., Tamari T., Brenner B. Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost: 2008; 100 5 878 885
50. Egorina E. M., Sovershaev M. A., Olsen J. O., Østerud B. Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood: 2008; 111 3 1208 1216
51. Baka Z., Senolt L., Vencovsky J., et al. Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis. Immunol Lett: 2010; 128 2 124 130
52. Shah M. D., Bergeron A. L., Dong J. F., López J. A. Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets: 2008; 19 5 365 372
53. Canellini G., Rubin O., Delobel J., Crettaz D., Lion N., Tissot J. D. Red blood cell microparticles and blood group antigens: an analysis by flow cytometry. Blood Transfus: 2012; 10 Suppl 2 s39 s45
54. Rubin O., Canellini G., Delobel J., Lion N., Tissot J. D. Red blood cell microparticles: clinical relevance. Transfus Med Hemother: 2012; 39 5 342 347
55. Rosse W. F., Gallagher D., Kinney T. R., et al. The Cooperative Study of Sickle Cell Disease Transfusion and alloimmunization in sickle cell disease. Blood: 1990; 76 7 1431 1437
56. Cox J. V., Steane E., Cunningham G., Frenkel E. P. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med: 1988; 148 11 2485 2489
57. Bosman G. J. Erythrocyte aging in sickle cell disease. Cell Mol Biol (Noisy-le-grand): 2004; 50 1 81 86
58. Westerman M., Pizzey A., Hirschman J., et al. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol: 2008; 142 1 126 135
59. van Beers E. J., Schaap M. C., Berckmans R. J., et al. CURAMA study group Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica: 2009; 94 11 1513 1519
60. Sadallah S., Eken C., Schifferli J. A. Erythrocyte-derived ectosomes have immunosuppressive properties. J Leukoc Biol: 2008; 84 5 1316 1325
61. Sadallah S., Eken C., Schifferli J. A. Ectosomes as modulators of inflammation and immunity. Clin Exp Immunol: 2011; 163 1 26 32
62. Morel O., Toti F., Freyssinet J. M. Markers of thrombotic disease: procoagulant microparticles [in French]. Ann Pharm Fr: 2007; 65 2 75 84
63. Ueba T., Haze T., Sugiyama M., et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost: 2008; 100 2 280 285
64. Lacroix R., Dignat-George F. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb Res: 2012; 129 Suppl 2 S27 S29
65. Forest A., Pautas E., Ray P., et al. Circulating microparticles and procoagulant activity in elderly patients. J Gerontol A Biol Sci Med Sci: 2010; 65 414 420
66. Jodo S., Xiao S., Hohlbaum A., Strehlow D., Marshak-Rothstein A., Ju S. T. Apoptosis-inducing membrane vesicles. A novel agent with unique properties. J Biol Chem: 2001; 276 43 39938 39944
67. Dye J. R., Ullal A. J., Pisetsky D. S. The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Scand J Immunol: 2013; 78 2 140 148
68. Pamuk G. E., Vural O., Turgut B., Demir M., Pamuk O. N., Cakir N. Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis? Platelets: 2008; 19 2 146 154
69. Sellam J., Proulle V., Jüngel A., et al. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther: 2009; 11 5 R156
70. van Eijk I. C., Tushuizen M. E., Sturk A., et al. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann Rheum Dis: 2010; 69 7 1378 1382
71. Biró E., Nieuwland R., Tak P. P., et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis: 2007; 66 8 1085 1092
72. Boilard E., Nigrovic P. A., Larabee K., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science: 2010; 327 5965 580 583
73. Berckmans R. J., Nieuwland R., Böing A. N., Romijn F. P., Hack C. E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost: 2001; 85 4 639 646
74. Turesson C., Jarenros A., Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis: 2004; 63 8 952 955
75. Maradit-Kremers H., Crowson C. S., Nicola P. J., et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum: 2005; 52 2 402 411
76. Maradit-Kremers H., Nicola P. J., Crowson C. S., Ballman K. V., Gabriel S. E. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum: 2005; 52 3 722 732
77. Solomon D. H., Goodson N. J., Katz J. N., et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis: 2006; 65 12 1608 1612
78. Bucciarelli P., Martinelli I., Artoni A., et al. Circulating microparticles and risk of venous thromboembolism. Thromb Res: 2012; 129 5 591 597
79. Holmqvist M. E., Neovius M., Eriksson J., et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA: 2012; 308 13 1350 1356
80. Choi H. K., Rho Y. H., Zhu Y., Cea-Soriano L., Aviña-Zubieta J. A., Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis: 2013; 72 7 1182 1187
81. Chung W. S., Peng C. L., Lin C. L., et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis: 2013
82. Beyer C., Pisetsky D. S. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol: 2010; 6 1 21 29
83. Iversen L. V., Østergaard O., Ullman S., et al. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis. Scand J Rheumatol: 2013; 42 6 473 482
84. Guiducci S., Distler J. H., Jüngel A., et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum: 2008; 58 9 2845 2853
85. Diehl P., Aleker M., Helbing T., et al. Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension. J Thromb Thrombolysis: 2011; 31 2 173 179
86. Maugeri N., Rovere-Querini P., Baldini M., et al. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis. Antioxid Redox Signal: 2014; 20 7 1060 1074
87. Ullal A. J., Reich C. F. III, Clowse M., et al. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun: 2011; 36 3-4 173 180
88. Ullal A. J., Pisetsky D. S. The role of microparticles in the generation of immune complexes in murine lupus. Clin Immunol: 2013; 146 1 1 9
89. Wloch M. K., Alexander A. L., Pippen A. M., Pisetsky D. S., Gilkeson G. S. Differences in V kappa gene utilization and VH CDR3 sequence among anti-DNA from C3H-lpr mice and lupus mice with nephritis. Eur J Immunol: 1996; 26 9 2225 2233
90. Nielsen C. T., Østergaard O., Johnsen C., Jacobsen S., Heegaard N. H. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum: 2011; 63 10 3067 3077
91. Østergaard O., Nielsen C. T., Iversen L. V., et al. Unique protein signature of circulating microparticles in systemic lupus erythematosus. Arthritis Rheum: 2013; 65 10 2680 2690
92. Manzi S., Meilahn E. N., Rairie J. E., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol: 1997; 145 5 408 415
93. Bruce I. N., Urowitz M. B., Gladman D. D., Ibañez D., Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum: 2003; 48 11 3159 3167
94. Esdaile J. M., Abrahamowicz M., Grodzicky T., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum: 2001; 44 10 2331 2337
95. Parker B., Al-Husain A., Pemberton P., et al. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Ann Rheum Dis: 2013
96. Chironi G. N., Boulanger C. M., Simon A., Dignat-George F., Freyssinet J. M., Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res: 2009; 335 1 143 151
97. Mayr M., Grainger D., Mayr U., et al. Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques. Circ Cardiovasc Genet: 2009; 2 4 379 388